Corvus Pharmaceuticals, Inc. Common Stock (NASDAQ: CRVS) last traded at $10.52, up 3.04% on the session. The quote above updates while this page is open; the figures below are drawn from Corvus Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Corvus Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker CRVS. Its market capitalisation is $884.95 million.
Valuation measures for Corvus Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $884.95M |
|---|---|
| Enterprise value | $879.99M |
| Price / book | 3.93 |
| Beta | -0.50 |
Trailing-twelve-month figures tagged in Corvus Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$54.13M |
| EPS (TTM) | -$0.640 |
|---|
| Return on equity | -24.02% |
|---|
| Cash | $18.91M |
|---|
Range and volume for CRVS over the past 52 weeks.
| 52-week high | $26.95 |
|---|---|
| 52-week low | $6.39 |
| Volume | 1.03M |
| Average volume | 986.8K |
| Previous close | $10.21 |
Invest a chosen dollar amount in Corvus Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CRVS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.